Theracurmin®

Innovative preparation of curcumin for improved oral bioavailability.

Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T.

Biol Pharm Bull. 2011; 34 (5): 660-665.

The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study.

Nakagawa Y, Mukai S, Yamada S, Murata S, Yabumoto H, Maeda T, Akamatsu S.

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2020 13: 1–8.
doi: 10.1177/1179544120948471.

TC044

The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain.

Erken N, Dost Gunay FS, Soysal P, Isik AT.

Clin Interv Aging. 2020 May 19;15:691-693. doi: 10.2147/CIA.S252229. eCollection 2020.

Short-term effects of Theracurmin dose and exercise type on pain, walking ability, and muscle function in patients with knee osteoarthritis.

Shin YA, Suk MH, Jang HS, Choi HJ.

J Exerc Rehabil. 2017 Dec; 13 (6): 684-692.

TC026

The effects of curcumin on Brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study.

Wynn JK, Green MF, Hellemann G, Karunaratne K, Davis MC, Marder SR.

Schizophrenia Res. 2018 May; 195: 572–573.

Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study.

Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, Tamura C, Imaizumi A, Nishihira J, Nakamura T.

J Orthop Sci. 2014 Nov; 19 (6): 933-939.